Ascendis Pharma A/S Current Tax Assets Current
Ascendis Pharma A/S (ASND) had Current Tax Assets Current of EUR 1.78 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:CurrentTaxAssetsCurrent · last filed 2026-02-11
- 2025-12-31: Current Tax Assets Current 1.78M EUR.
- 2025-09-30: Current Tax Assets Current 2.94M EUR.
- 2025-06-30: Current Tax Assets Current 2.74M EUR.
- 2025-03-31: Current Tax Assets Current 1.61M EUR.
| Period end | Current Tax Assets Current |
|---|---|
| 2025-12-31 | 1.78M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 2.94M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 2.74M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 1.61M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 1.77M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 2.00M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 1.84M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 742.00K EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 802.00K EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 1.64M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 1.36M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 1.06M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 883.00K EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 883.00K EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 1.63M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 1.13M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 1.07M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 893.00K EUR 20-F · filed 2023-02-16 |
| 2020-12-31 | 0.00 EUR 20-F · filed 2022-03-02 |
| 2020-09-30 | 1.30M EUR 6-K · filed 2020-11-12 |
| 2020-06-30 | 1.11M EUR 6-K · filed 2020-08-27 |
| 2020-03-31 | 921.00K EUR 6-K · filed 2020-05-19 |
| 2019-12-31 | 1.47M EUR 6-K · filed 2020-11-12 |
| 2019-09-30 | 1.30M EUR 6-K · filed 2019-11-18 |
| 2019-06-30 | 1.13M EUR 6-K · filed 2019-08-28 |
| 2019-03-31 | 962.00K EUR 6-K · filed 2019-05-30 |
| 2018-12-31 | 849.00K EUR 20-F · filed 2020-04-03 |
| 2018-09-30 | 1.49M EUR 6-K · filed 2018-11-28 |
| 2018-06-30 | 1.28M EUR 6-K · filed 2018-08-29 |
| 2018-03-31 | 1.07M EUR 6-K · filed 2018-05-30 |
| 2017-12-31 | 778.00K EUR 20-F · filed 2019-04-03 |
| 2016-12-31 | 740.00K EUR 20-F · filed 2018-03-28 |